The effect of resistance training on fatty liver disease

Comparison of the effects of circuite and conventional resistance training on some Inflammatory factors, insulin resistance and liver enzymes in men with non-alcoholic fatty liver disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190217042730N1

Enrollment

Registered

2019-04-07

Start date

2019-02-09

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatty liver disease. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention 1: First intervention group: circuit resistance training: For the purpose of training variation and reducing exercise uniformity, as well as strengthening muscles at different angles of t

Eligibility

Sex/Gender

Male

Age

35 Years to 50 Years

Inclusion criteria

Inclusion criteria: Men with non-alcoholic fatty liver with grade 2-1

Exclusion criteria

Exclusion criteria: Having other inflammatory diseases including rheumatoid arthritis and MS and .... Lifestyle with Mobility (VO2max) More than 40 mg / dl. Use of cigarettes and alcohol

Design outcomes

Primary

Measure	Time frame
Interleukin 17. Timepoint: Blood sampling is performed one day before the intervention and 12 weeks after the intervention. Method of measurement: German Zelbio kit by ELISA method.;Thermal shock protein70 kDa. Timepoint: Blood sampling is performed one day before the intervention and 12 weeks after the intervention. Method of measurement: German Zelbio kit by ELISA method.;Insulin resistance. Timepoint: Blood sampling is performed one day before the intervention and 12 weeks after the intervention. Method of measurement: HOMA-IR={Fasting blood glucose (mmol/ml) × fasting insulin (microunits/ml)} ÷ 22/5.;Alanine aminotransferase enzyme. Timepoint: Blood sampling is performed one day before the intervention and 12 weeks after the intervention. Method of measurement: Pars Azmoon kit by ELISA method.;Aspartate aminotransferase enzyme. Timepoint: Blood sampling is performed one day before the intervention and 12 weeks after the intervention. Method of measurement: Pars Azmoon kit by ELISA method.	—

Measure

Time frame

Interleukin 17. Timepoint: Blood sampling is performed one day before the intervention and 12 weeks after the intervention. Method of measurement: German Zelbio kit by ELISA method.;Thermal shock protein70 kDa. Timepoint: Blood sampling is performed one day before the intervention and 12 weeks after the intervention. Method of measurement: German Zelbio kit by ELISA method.;Insulin resistance. Timepoint: Blood sampling is performed one day before the intervention and 12 weeks after the intervention. Method of measurement: HOMA-IR={Fasting blood glucose (mmol/ml) × fasting insulin (microunits/ml)} ÷ 22/5.;Alanine aminotransferase enzyme. Timepoint: Blood sampling is performed one day before the intervention and 12 weeks after the intervention. Method of measurement: Pars Azmoon kit by ELISA method.;Aspartate aminotransferase enzyme. Timepoint: Blood sampling is performed one day before the intervention and 12 weeks after the intervention. Method of measurement: Pars Azmoon kit by ELISA method.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoud Nikbakht

Islamic Azad University

sport.nikbakht@gmail.com+98 61 4242 0601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026